Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMD
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical [...]
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical [...]
The study, published in The March 2026 edition of Federal [...]
The Journal of the American Medical Association (JAMA Neurology) publication [...]
Verve Medical, the leader in non‑invasive renal pelvic denervation (RPD) [...]
Following End-of-Phase 2 meeting, MBX remains on track to initiate [...]
The company is expected to finalize the Clinical Study Report [...]
Findings published in Nature uncover a microbiome-driven pathway that turns [...]
“This rigorous head-to-head study provides high-quality evidence that POSLUMA has [...]
The study was published in the peer-reviewed journal Bioactive Compounds [...]
Trial Evaluates Safety, Right Heart Functional Improvement, and Clinical Outcomes [...]